Search Clinical Trials Search
Clinical Trials
× ...
Sort & Filter
Sort by
Specialty

Disease or Condition

Age Group


Drug/Medication


401 results found


Unknown Sites

Exelixis, Inc., XL092-311, Ph 2/3, randomized, Zanzalinitinib vs Everolimus, Neuroendocrine tumors

Primary Objective: To evaluate progression-free survival (PFS) by blinded independent central review (BICR) of zanzalintinib versus everolimus Secondary Objectives: To evaluate objective response rate (ORR) by BICR of zanzalintinib versus everolimus To evaluate overall survival (OS) of ...